156 related articles for article (PubMed ID: 15380928)
21. Endothelin-1 (ET-1)-potentiated insulin secretion: involvement of protein kinase C and the ET(A) receptor subtype.
Gregersen S; Thomsen JL; Hermansen K
Metabolism; 2000 Feb; 49(2):264-9. PubMed ID: 10690956
[TBL] [Abstract][Full Text] [Related]
22. The nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester potentiates insulin secretion stimulated by glucose and L-arginine independently of its action on ATP-sensitive K+ channels.
Salehi A; Parandeh F; Lundquist I
Biosci Rep; 1998 Feb; 18(1):19-28. PubMed ID: 9653515
[TBL] [Abstract][Full Text] [Related]
23. Imidazoline-induced amplification of glucose- and carbachol-stimulated insulin release includes a marked suppression of islet nitric oxide generation in the mouse.
Meidute-Abaraviciene S; Mosen H; Lundquist I; Salehi A
Acta Physiol (Oxf); 2009 Mar; 195(3):375-83. PubMed ID: 18764864
[TBL] [Abstract][Full Text] [Related]
24. Arginine-induced insulin release is decreased and glucagon increased in parallel with islet NO production.
Henningsson R; Lundquist I
Am J Physiol; 1998 Sep; 275(3):E500-6. PubMed ID: 9725818
[TBL] [Abstract][Full Text] [Related]
25. Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets.
Aring;kesson B; Lundquist I
J Physiol; 1999 Mar; 515 ( Pt 2)(Pt 2):463-73. PubMed ID: 10050013
[TBL] [Abstract][Full Text] [Related]
26. Nitric oxide and hydroperoxide affect islet hormone release and Ca(2+) efflux.
Akesson B; Lundquist I
Endocrine; 1999 Aug; 11(1):99-107. PubMed ID: 10668648
[TBL] [Abstract][Full Text] [Related]
27. Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase.
Gao Z; Konrad RJ; Collins H; Matschinsky FM; Rothenberg PL; Wolf BA
Diabetes; 1996 Jul; 45(7):854-62. PubMed ID: 8666133
[TBL] [Abstract][Full Text] [Related]
28. Glucagon decreases cytokine induction of nitric oxide synthase and action on insulin secretion in RIN5F cells and rat and human islets of Langerhans.
Belin VD; Mabley JG; James RF; Swift SM; Clayton HA; Titheradge MA; Green IC
Cytokine; 1999 Aug; 11(8):585-92. PubMed ID: 10433805
[TBL] [Abstract][Full Text] [Related]
29. Glucagon-like peptide-1 stimulates insulin secretion but not phosphoinositide hydrolysis from islets desensitized by prior exposure to high glucose or the muscarinic agonist carbachol.
Zawalich WS; Zawalich KC
Metabolism; 1996 Feb; 45(2):273-8. PubMed ID: 8596502
[TBL] [Abstract][Full Text] [Related]
30. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
31. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B.
Zhao AZ; Bornfeldt KE; Beavo JA
J Clin Invest; 1998 Sep; 102(5):869-73. PubMed ID: 9727054
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide (NO)--production and regulation of insulin secretion in islets of freely fed and fasted mice.
Eckersten D; Henningsson R
Regul Pept; 2012 Feb; 174(1-3):32-7. PubMed ID: 22120830
[TBL] [Abstract][Full Text] [Related]
33. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
Parkes DG; Pittner R; Jodka C; Smith P; Young A
Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
[TBL] [Abstract][Full Text] [Related]
34. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells.
Buteau J; Roduit R; Susini S; Prentki M
Diabetologia; 1999 Jul; 42(7):856-64. PubMed ID: 10440129
[TBL] [Abstract][Full Text] [Related]
35. Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release: a biochemical, immunohistochemical, and confocal microscopic study.
Henningsson R; Alm P; Ekström P; Lundquist I
Diabetes; 1999 Jan; 48(1):66-76. PubMed ID: 9892224
[TBL] [Abstract][Full Text] [Related]
36. The Rap-B-Raf signalling pathway is activated by glucose and glucagon-like peptide-1 in human islet cells.
Trümper J; Ross D; Jahr H; Brendel MD; Göke R; Hörsch D
Diabetologia; 2005 Aug; 48(8):1534-40. PubMed ID: 15995848
[TBL] [Abstract][Full Text] [Related]
37. Dual role for nitric oxide in dynorphin spinal neurotoxicity.
Hu WH; Li F; Qiang WA; Liu N; Wang GQ; Xiao J; Liu JS; Liao WH; Jen MF
J Neurotrauma; 1999 Jan; 16(1):85-98. PubMed ID: 9989468
[TBL] [Abstract][Full Text] [Related]
38. Time-dependent stimulation of insulin exocytosis by 3',5'-cyclic adenosine monophosphate in the rat islet beta-cell.
Yamada S; Komatsu M; Sato Y; Yamauchi K; Kojima I; Aizawa T; Hashizume K
Endocrinology; 2002 Nov; 143(11):4203-9. PubMed ID: 12399413
[TBL] [Abstract][Full Text] [Related]
39. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice.
Salehi A; Dornonville de la Cour C; Håkanson R; Lundquist I
Regul Pept; 2004 May; 118(3):143-50. PubMed ID: 15003830
[TBL] [Abstract][Full Text] [Related]
40. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
Lawrence MC; Bhatt HS; Easom RA
Diabetes; 2002 Mar; 51(3):691-8. PubMed ID: 11872668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
